SCHEMBL14985487

SCHEMBL14985487

C/C(=N/O)c1cc(Br)ccc1F

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH2 P05091 1/20 0.50
ALDH1A3 P47895 1/20 0.50
ESR1 P03372 2/20 0.45
ESR2 Q92731 2/20 0.45
MGLL Q99685 1/20 0.45
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
DGAT1 O75907 1/20 0.39
CTDSP1 Q9GZU7 1/20 0.36
TRPA1 O75762 1/20 0.35
TP53 P04637 1/20 0.35
CES2 O00748 1/20 0.34
GALR3 O60755 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34
HPGD P15428 1/20 0.34
ALOX15 P16050 1/20 0.34
CASP1 P29466 1/20 0.34
CYP2C19 P33261 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28905087 0.85 DGAT1 (0.52) ALDH2ALDH1A3ESR1ESR2MGLL
SCHEMBL17907309 0.83 DGAT1 (0.42) ALDH2ALDH1A3MEN1KMT2ADGAT1
SCHEMBL16532097 0.83 DGAT1 (0.42) ALDH2ALDH1A3MEN1KMT2ADGAT1
SCHEMBL18509639 0.83 DGAT1 (0.38) ALDH2ALDH1A3KMT2ADGAT1CTDSP1
SCHEMBL18509638 0.80 DGAT1 (0.36) ALDH2ALDH1A3MEN1KMT2ADGAT1
SCHEMBL16960361 0.79 DGAT1 (0.44) KMT2ADGAT1TP53CES2GALR3
SCHEMBL21317684 0.79 ALDH2 (0.39) ALDH2ALDH1A3KMT2ADGAT1CTDSP1
SCHEMBL14230833 0.78 ESR1 (0.58) ALDH2ALDH1A3ESR1ESR2MGLL
SCHEMBL14230831 0.78 ESR1 (0.58) ALDH2ALDH1A3ESR1ESR2MGLL
SCHEMBL31107436 0.78 ESR1 (0.58) ALDH2ALDH1A3ESR1ESR2MGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013078440-A2 ENHANCED TREATMENT REGIMENS USING MTOR INHIBITORS INTELLIKINE, LLC (US) 2013-05-30 WO disclosed